XML 76 R51.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Domestic and Foreign Components of Loss from Continuing Operations Before Income Taxes

The domestic and foreign components of loss from continuing operations before income taxes for the years ended December 31, 2024 and 2023 are as follows (in thousands):

 

   For the Years Ended
December 31,
 
   2024   2023 
Domestic  $(30,876)  $(25,066)
Foreign   (4,711)    
Net Loss, before tax  $(35,587)  $(25,066)
Schedule of Reconciliation Between the U.S. Statutory Federal Income Tax Rate and Company’s Effective Rate

The income tax provision (benefit) for the years ended December 31, 2024 and 2023 consists of the following (in thousands):

 

   For the Years Ended
December 31,
 
   2024   2023 
Foreign        
Current  $   $ 
Deferred   (1,088)    
U.S. federal          
Current        
Deferred   (4,023)   (1,647)
State and local          
Current   16     
Deferred   (1,061)   (345)
    (6,156)   (1,992)
Change in valuation allowance   6,172    1,992 
Income Tax Provision (Benefit)  $16   $ 
Schedule of Reconciliation Between the U.S. Statutory Federal Income Tax Rate and Company’s Effective Rate

The reconciliation between the U.S. statutory federal income tax rate and the Company’s effective rate for the years ended December 31, 2024 and 2023 is as follows:

 

   For the Years Ended
December 31,
 
   2024   2023 
U.S. federal statutory rate   21.0%   21.0%
State income taxes, net of federal benefit   2.2%   4.4%
162(m) compensation limit   (7.1)%   (0.2)%
Transaction costs   (2.1)%   %
Convertible notes / warrant inducement expense   (3.8)%   (6.7)%
Convertible notes – fair value adjustment   7.3%   (9.7)%
Foreign income tax rate difference   0.8%   %
Other permanent items   (1.8)%   (1.0)%
Provision to return adjustment   0.1%   %
Rate change   0.1%   %
Other   (0.1)%   (0.8)%
Change in valuation allowance   (16.6)%   (7.0)%
Effective Rate   (0.0)%   0.0%
Schedule of Company’s Deferred Tax Assets and Liabilities

As of December 31, 2024 and 2023, the Company’s deferred tax assets and liabilities consisted of the effects of temporary differences attributable to the following (in thousands):

 

   As of December 31, 
   2024   2023 
Deferred Tax Asset        
Loss carryovers  $59,366   $3,867 
Stock based compensation   4,103    2,443 
Research credits        
Accrued expenses   791    1,348 
Reserves        
Intangibles   181     
Fixed assets        
Unrealized gain   144     
Section 174 capital research   3,955    866 
Other   702      
           
Total Deferred Tax Asset   69,242    8,524 
Less: valuation allowance   (69,017)   (8,524)
Deferred Tax Asset, Net of Valuation Allowance  $225   $ 

 

   As of December 31, 
  2024   2023 
Deferred Tax Liabilities        
Intangible assets  $   $ 
Fixed assets   (7)    
Other   (218)    
Capitalized research        
Total deferred tax liabilities   (225)    
Net Deferred Tax Asset (Liability)  $   $